CAI Q3 2014 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+9.8% YoY

Gross Profit

$39M66.4% margin

Operating Income

$26M43.9% margin

Net Income

$16M27.7% margin

EPS (Diluted)

$0.77

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

-$26M

Stock-Based Comp.

$522,000

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.4B

Stockholders' Equity

$427M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$54M	+9.8%
Gross Profit	$39M	$37M	+7.7%
Operating Income	$26M	$25M	+3.0%
Net Income	$16M	$15M	+6.9%